PlainRecalls
FDA Drug Moderate Class II Ongoing

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

Reported: June 26, 2024 Initiated: June 4, 2024 #D-0561-2024

Product Description

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

Reason for Recall

Subpotent Drug

Details

Units Affected
34,448 bottles
Distribution
Nationwide within the United States
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34. Recalled by Teva Pharmaceuticals USA, Inc. Units affected: 34,448 bottles.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on June 26, 2024. Severity: Moderate. Recall number: D-0561-2024.